The RNA Component of Human Telomerase
The DOI matches its Crossref record; 44 of the 44 references it cites were found in a registry or an index.
Abstract
Eukaryotic chromosomes are capped with repetitive telomere sequences that protect the ends from damage and rearrangements. Telomere repeats are synthesized by telomerase, a ribonucleic acid (RNA)-protein complex. Here, the cloning of the RNA component of human telomerase, termed hTR, is described. The template region of hTR encompasses 11 nucleotides (5′-CUAACCCUAAC) complementary to the human telomere sequence (TTAGGG) n . Germline tissues and tumor cell lines expressed more hTR than normal somatic cells and tissues, which have no detectable telomerase activity. Human cell lines that expressed hTR mutated in the template region generated the predicted mutant telomerase activity. HeLa cells transfected with an antisense hTR lost telomeric DNA and began to die after 23 to 26 doublings. Thus, human telomerase is a critical enzyme for the long-term proliferation of immortal tumor cells.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Key components of telomerase are telomerase reverse transcriptase (TERT) (88) and telomerase RNA (89).”
From The Discovery of Reverse Transcriptase (2016) · cites this paper as [89]
In the citing paper
“expression of antisense RNA complementary to the human telomerase RNA component (hTR) caused decreased proliferation of HeLa cells after 23 to 26 doublings (24).”
From Inhibition of human telomerase in immortal human cells leads to progressive telomere shortening and cell death (1999) · cites this paper as [24]
In the citing paper
“The shortening of telomeres occurs with each cell division, ultimately causing cells to reach their Hayflick limit, whereby growth stops after approximately 60 times population doubling [2,3,4,5].”
From Cell Immortality: In Vitro Effective Techniques to Achieve and Investigate Its Applications and Challenges (2024) · cites this paper as [5]
In the citing paper
“When telomeres become too short and cannot function naturally, cellular senescence in the M1 phase (a cellular growth arrest, also called the M1 stage) occurs [5,6,7].”
From Cell Immortality: In Vitro Effective Techniques to Achieve and Investigate Its Applications and Challenges (2024) · cites this paper as [5]
In the citing paper
“In human cells, the enzyme comprises a high molecular weight complex with a template-containing RNA subunit (Feng et al., 1995) and protein components including the catalytic subunit human telomerase reverse transcriptase, hTERT (Harrington et al., 1997;Meyerson et al., 1997;Nakamura et al., 1997).”
From A highly selective telomerase inhibitor limiting human cancer cell proliferation (2001) · cites this paper as Feng et al., 1995
Citations
Cites
DNA sequencing with chain-terminating inhibitors
Sanger, F., Nicklen, S., & Coulson, A. R. (1977) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.74.12.5463 · Cited by 68,572
Specific Association of Human Telomerase Activity with Immortal Cells and Cancer
Kim, N. W., Piatyszek, M. A., Prowse, K. R., Harley, C. B., West, M. D., Ho, P. L. C., Coviello, G. M., Wright, W. E., Weinrich, S. L., & Shay, J. W. (1994) · Science · doi:10.1126/science.7605428 · Cited by 7,091
Self-citationTelomeres shorten during ageing of human fibroblasts
Harley, C. B., Futcher, A. B., & Greider, C. W. (1990) · Nature · doi:10.1038/345458a0 · Cited by 5,750
Self-citationTight control of gene expression in mammalian cells by tetracycline-responsive promoters.
Gossen, M., & Bujard, H. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.12.5547 · Cited by 4,943
Identification of a specific telomere terminal transferase activity in tetrahymena extracts
Greider, C. W., & Blackburn, E. H. (1985) · Cell · doi:10.1016/0092-8674(85)90170-9 · Cited by 3,400
Self-citationTelomere length predicts replicative capacity of human fibroblasts.
Allsopp, R. C., Vaziri, H., Patterson, C., Goldstein, S., Younglai, E. V., Futcher, A. B., Greider, C. W., & Harley, C. B. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.21.10114 · Cited by 2,200
Self-citationCounter, C. M., Avilion, A. A., LeFeuvre, C. E., Stewart, N. G., Greider, C. W., Harley, C. B., & Bacchetti, S. (1992) · The EMBO Journal · doi:10.1002/j.1460-2075.1992.tb05245.x · Cited by 2,096
Self-citationOlovnikov (1973) · doi:10.1016/0022-5193(73)90198-7 · Cited by 1,847
Telomere reduction in human colorectal carcinoma and with ageing
Hastie, N. D., Dempster, M., Dunlop, M. G., Thompson, A. M., Green, D. K., & Allshire, R. C. (1990) · Nature · doi:10.1038/346866a0 · Cited by 1,650
A telomeric sequence in the RNA of Tetrahymena telomerase required for telomere repeat synthesis
Greider, C. W., & Blackburn, E. H. (1989) · Nature · doi:10.1038/337331a0 · Cited by 1,643
Self-citation
Research works printed but not linked: 7
- AUTEXIER, C, FUNCTIONAL RECONSTITUTION OF WILD-TYPE AND MUTANT TETRAHYMENA TELOMERASE, GENES & DEVELOPMENT 8: 563 (1994). · DOI
- AVILION A.A. THESIS STATE U NEW Y (1995).
- Broccoli, D., Proceedings of the National Academy of Sciences of the United States of America 92: 9082 (1995).
- CHADENEAU, C, ONCOGENE 11: 841 (1995).
- Hernandez, N., Transcriptional Regulation: 281 (1992).
- Muller, H. J., Collecting Net 13: 181 (1938).
- WATSON, J. D., NATURE-NEW BIOLOGY 239: 197 (1972).
Cited by
Items 301–400 of 1,004
Gable, D. L., Gaysinskaya, V., Atik, C. C., Talbot, C. C., Kang, B., Stanley, S. E., Pugh, E. W., Amat-Codina, N., Schenk, K. M., Arcasoy, M. O., et al. (2019) · Genes & Development · doi:10.1101/gad.326785.119 · Cited by 121
The illusion of cell immortality
Hayflick, L. (2000) · British Journal of Cancer · doi:10.1054/bjoc.2000.1296 · Cited by 124
Dyskeratosis congenita: telomerase, telomeres and anticipation
Marrone, A., Walne, A. J., & Dokal, I. S. (2005) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2005.04.004 · Cited by 134
Nucleolin Interacts with Telomerase
Shilagardi, K., Masutomi, K., Luvsanjav, D., Arai, K., Oishi, N., Mizuno, H., Hayashi, N., Hahn, W. C., & Murakami, S. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m407643200 · Cited by 124
Telomerase reverse transcriptase genes identified in Tetrahymena thermophila and Oxytricha trifallax
Bryan, T. M., Sperger, J. M., Chapman, K. B., & Cech, T. R. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.15.8479 · Cited by 126
Autexier, C., Pruzan, R., Funk, W. D., & Greider, C. W. (1996) · The EMBO Journal · doi:10.1002/j.1460-2075.1996.tb00979.x · Cited by 145
Self-citationGuo, Y., Kartawinata, M., Li, J., Pickett, H. A., Teo, J., Kilo, T., Barbaro, P. M., Keating, B., Chen, Y., Tian, L., et al. (2014) · Blood · doi:10.1182/blood-2014-08-596445 · Cited by 120
“2008;111(9):4523-4531 For personal use only.”
Telomerase activity and alterations in telomere length in human brain tumors.
Hiraga, S., Ohnishi, T., Izumoto, S., Miyahara, E., Kanemura, Y., Matsumura, H., & Arita, N. (1998) · PubMed · Cited by 133
Tesmer, V. M., Ford, L. P., Holt, S. E., Frank, B. C., Yi, X., Aisner, D. L., Ouellette, M., Shay, J. W., & Wright, W. E. (1999) · Molecular and Cellular Biology · doi:10.1128/mcb.19.9.6207 · Cited by 121
Bachand, F., & Autexier, C. (2001) · Molecular and Cellular Biology · doi:10.1128/mcb.21.5.1888-1897.2001 · Cited by 124
Evolutionary perspectives of telomerase RNA structure and function
Podlevsky, J. D., & Chen, J. J. ‐. (2016) · RNA Biology · doi:10.1080/15476286.2016.1205768 · Cited by 133
“3).(48) Telomerases from different groups of species”
Use of exogenous hTERT to immortalize primary human cells
Lee, K. M., Choi, K. H., & Ouellette, M. M. (2004) · Cytotechnology · doi:10.1007/10.1007/s10616-004-5123-3 · Cited by 145
“The first provides catalytic activity and the second contains a short sequence (5¢-CUAACCCUAAC-3¢) that the enzyme utilizes as an internal template for the synthesis of telomeric repeats (Feng et al. 1995; Harrington et al. 1997; Kilian et al. 1997; Meyerson et al. 1997; Nakamura et al. 1997).”
BackgroundWolf, S. A., Melnik, A., & Kempermann, G. (2010) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2010.10.014 · Cited by 129
“Stem cells thus exhibit high levels of telomerase (TERT); an enzyme that adds a six-base DNA repeat sequence (TTAGGG) to chromosome ends and thereby prevents telomere shortening during mitosis (Blackburn, 2005; Feng et al., 1995; Flores et al., 2006, 2008).”
Physiological assembly and activity of human telomerase complexes
Collins, K. (2007) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2007.10.008 · Cited by 133
“For example, mature hTR lacks the polyadenosine tail of a mRNA and bears a 50 tri-methyl rather than mono-methyl guanosine cap (Feng et al., 1995; Fu and Collins, 2006).”
BackgroundNew prospects for targeting telomerase beyond the telomere
Arndt, G. M., & MacKenzie, K. L. (2016) · Nature reviews. Cancer · doi:10.1038/nrc.2016.55 · Cited by 131
TelomereHunter – in silico estimation of telomere content and composition from cancer genomes
Feuerbach, L., Sieverling, L., Deeg, K. I., Ginsbach, P., Hutter, B., Buchhalter, I., Northcott, P. A., Mughal, S. S., Chudasama, P., Glimm, H., et al. (2019) · BMC Bioinformatics · doi:10.1186/s12859-019-2851-0 · Cited by 123
Telomeres and telomerase: biological and clinical importance
Dahse, R., Fiedler, W., & Ernst, G. (1997) · Clinical Chemistry · doi:10.1093/clinchem/43.5.708 · Cited by 121
“Recently, the telomerase RNAs of yeasts and humans have been cloned [12, 13].”
Zhou, J.-M., Zhu, X.-F., Lu, Y.-J., Deng, R., Huang, Z.-S., Mei, Y.-P., Wang, Y., Huang, W.-L., Liu, Z.-C., Gu, L.-Q., et al. (2005) · Oncogene · doi:10.1038/sj.onc.1209067 · Cited by 126
“It is a large RNA-dependent DNA polymerase that uses its own associated RNA template to catalyse the addition of telomeric DNA repeats to the 30-end of the singlestranded DNA telomere (Feng et al., 1995; Nakamura et al., 1997).”
BackgroundOligonucleotide N3′→P5′ phosphoramidates as efficient telomerase inhibitors
Herbert, B., Pongracz, K., Shay, J. W., & Gryaznov, S. M. (2002) · Oncogene · doi:10.1038/sj.onc.1205064 · Cited by 131
Alder, J. K., Cogan, J. D., Brown, A. F., Anderson, C. J., Lawson, W. E., Lansdorp, P. M., Phillips, J. A., Loyd, J. E., Chen, J. J.-L., & Armanios, M. (2011) · PLoS Genetics · doi:10.1371/journal.pgen.1001352 · Cited by 119
“Telomerase has two essential conserved components, a catalytic reverse transcriptase, hTERT, and an RNA component, hTR [3,4].”
BackgroundFor Better or Worse? Telomerase Inhibition and Cancer
de Lange, T., & Jacks, T. (1999) · Cell · doi:10.1016/s0092-8674(00)81955-8 · Cited by 119
Lee, M., Hills, M., Conomos, D., Stutz, M. D., Dagg, R. A., Lau, L. M. S., Reddel, R. R., & Pickett, H. A. (2014) · Nucleic Acids Research · doi:10.1093/nar/gkt1117 · Cited by 116
Herndon, J. E., Fleishman, S., Kornblith, A. B., Kosty, M., Green, M. R., & Holland, J. (1999) · Cancer · doi:10.1002/(sici)1097-0142(19990115)85:2<333::aid-cncr10>3.0.co;2-q · Cited by 193
Arai, J., Yasukawa, M., Ohminami, H., Kakimoto, M., Hasegawa, A., & Fujita, S. (2001) · Blood · doi:10.1182/blood.v97.9.2903 · Cited by 117
Identification and characterization of the Schizosaccharomyces pombe TER1 telomerase RNA
Webb, C. J., & Zakian, V. A. (2007) · Nature Structural & Molecular Biology · doi:10.1038/nsmb1354 · Cited by 133
Mitochondria, Telomeres and Telomerase Subunits
Zheng, Q., Huang, J., & Wang, G. (2019) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2019.00274 · Cited by 111
“No effect of long-term CR on human IGF-1 levels has been observed (Fontana et al., 2008).”
BackgroundNucleolar Localization of hTERT Protein Is Associated with Telomerase Function
Yang, Y., Chen, Y., Zhang, C., Huang, H., & Weissman, S. M. (2002) · Experimental Cell Research · doi:10.1006/excr.2002.5541 · Cited by 128
Liu, X., Yuan, H., Fu, B., Disbrow, G. L., Apolinario, T., Tomaić, V., Kelley, M. L., Baker, C. C., Huibregtse, J., & Schlegel, R. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m410343200 · Cited by 99
Egan, E. D., & Collins, K. (2010) · Molecular and Cellular Biology · doi:10.1128/mcb.00151-10 · Cited by 111
“The 451-nucleotide (nt) mature human telomerase RNA (hTR) is produced by 3 end trimming and 5 end modification with a trimethylguanosine (TMG) cap (15, 17, 21, 28).”
Ludwig, A., Saretzki, G. C., Holm, P. S., Tiemann, F., Lorenz, M., Emrich, T., Harley, C. B., & von Zglinicki, T. (2001) · PubMed · doi:10.25405/ncl.34663959 · Cited by 138
Self-citationFujimoto, K., Kyo, S., Takakura, M., Kanaya, T., Kitagawa, Y., Itoh, H., Takahashi, M., & Inoue, M. (2000) · Nucleic Acids Research · doi:10.1093/nar/28.13.2557 · Cited by 116
Marek’s disease virus: lytic replication, oncogenesis and control
Jarosinski, K. W., Tischer, B. K., Trapp, S., & Osterrieder, N. (2006) · Expert Review of Vaccines · doi:10.1586/14760584.5.6.761 · Cited by 116
Nucleases of the Metallo-β-lactamase Family and Their Role in DNA and RNA Metabolism
Dominski, Z. (2007) · Critical Reviews in Biochemistry and Molecular Biology · doi:10.1080/10409230701279118 · Cited by 115
“Among potential substrates for Integrator are the RNA component of telomerase (Feng et al., 1995; Fu and Collins, 2003) and individually transcribed small nucleolar RNAs (snoRNA), including U3 and U8 snoRNAs (Watkins et al., 2004).”
BackgroundCuthbert, A. P., Bond, J., Trott, D. A., Gill, S., Broni, J., Marriott, A., Khoudoli, G., Parkinson, E. K., Cooper, C. S., & Newbold, R. F. (1999) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/91.1.37 · Cited by 114
“Hyg-3/21NT (5) 46 36 (78) 10 ( 22 ) Neo-3/21NT (1) 30 20 (67) 10 (33) Hyg-8/21NT (5) 73 8 (11) 65 (89) Hyg-20/21NT (1) 24 2 (8) 22 (92)”
The Tug1 lncRNA locus is essential for male fertility
Lewandowski, J. P., Dumbović, G., Watson, A. R., Hwang, T., Jacobs-Palmer, E., Chang, N. P., Much, C., Turner, K. M., Kirby, C., Schulz, J. F., et al. (2020) · Genome biology · doi:10.1186/s13059-020-02081-5 · Cited by 120
“machines such as telomerase and the ribosome are comprised of proteins and noncoding RNAs and serve as classic examples of RNA-based functionalities [1, 2].”
BackgroundWang, Z., Kyo, S., Takakura, M., Tanaka, M., Yatabe, N., Maida, Y., Fujiwara, M., Hayakawa, J., Ohmichi, M., Koike, K., et al. (2000) · PubMed · Cited by 128
Telomerase inhibition as cancer therapy
Saretzki, G. C. (2003) · Cancer Letters · doi:10.1016/s0304-3835(02)00708-5 · Cited by 120
“[5] J.”
BackgroundImetelstat (GRN163L) - Telomerase-Based Cancer Therapy
Röth, A., Harley, C. B., & Baerlocher, G. M. (2009) · Recent results in cancer research/Recent Results in Cancer Research · doi:10.1007/978-3-642-01222-8_16 · Cited by 126
“oligonucleotides Antisense molecule Blocking hTR or hTERT ( Feng et al. 1995; Koga et al. 2001; Kondo et al. 1998; Kushner et al. 2000; Yatabe et al. 2002)”
BackgroundSelf-citationMajumdar, A. S., Hughes, D. E., Lichtsteiner, S., Wang, Z., LEBKOWSKI, J. S., & Vasserot, A. P. (2001) · Gene Therapy · doi:10.1038/sj.gt.3301421 · Cited by 128
Telomerase Activity in Primary Prostate Cancer
Lin, Y., Uemura, H., Fujinami, K., Hosaka, M., Harada, M., & Kubota, Y. (1997) · The Journal of Urology · doi:10.1016/s0022-5347(01)65160-7 · Cited by 113
Zheng, G., Daniel, W. L., & Mirkin, C. A. (2008) · Journal of the American Chemical Society · doi:10.1021/ja803035p · Cited by 112
Koga, S., Hirohata, S., Kondo, Y., Komata, T., Takakura, M., Inoue, M., Kyo, S., & Kondo, S. (2000) · Human Gene Therapy · doi:10.1089/10430340050057477 · Cited by 112
“Three components of the human telomerase have been identified: the RNA component (hTR) (Feng et al. , 1995), the telomerase-asso ciated protein (TEP1) (Harrington et al. , 1997; Nakayama et al. , 1997), and the telomerase catalytic subunit or telomerase reverse transcriptase (hTERT) (Meyerson et…”
Role of Telomerase in Cell Senescence and Oncogenesis
Urquidi, V., Tarin, D., & Goodison, S. (2000) · Annual Review of Medicine · doi:10.1146/annurev.med.51.1.65 · Cited by 123
Interplay between telomere length and telomerase in human leukocyte differentiation and aging
Weng, N. (2001) · Journal of Leukocyte Biology · doi:10.1189/jlb.70.6.861 · Cited by 115
“Although not all the components of telomerase holoenzyme have been identified, the core components of telomerase consist of telomerase-reverse transcriptase [8, 9] and telomerase RNA template [ 10 ].”
BackgroundLong non-coding RNAs in genitourinary malignancies: a whole new world
Flippot, R., Beinse, G., Boilève, A., Vibert, J., & Malouf, G. G. (2019) · Nature Reviews Urology · doi:10.1038/s41585-019-0195-1 · Cited by 109
Pérez-Rivero, G., Ruiz-Torres, M. P., Rivas-Elena, J. V., Jerkic, M., Díez-Marques, M. L., Lopez-Novoa, J. M., Blasco, M. A., & Rodríguez-Puyol, D. (2006) · Circulation · doi:10.1161/circulationaha.105.611111 · Cited by 108
Telomere length regulates ISG15 expression in human cells
Lou, Z., Wei, J., Riethman, H., Baur, J. A., Voglauer, R., Shay, J. W., & Wright, W. E. (2009) · Aging · doi:10.18632/aging.100066 · Cited by 101
“The RNA component hTR (hTERC) [10] contains a C-rich sequence that serves as a template for the addition of TTAGGG repeats using the reverse transcriptase activity contained within the protein catalytic subunit hTERT [11, 12].”
BackgroundAlternative Lengthening of Telomeres in Human Cells
Reddel, R. R., Bryan, T. M., Colgin, L. M., Perrem, K. T., & Yeager, T. R. (2001) · Radiation Research · doi:10.1667/0033-7587(2001)155[0194:alotih]2.0.co;2 · Cited by 110
Kim, E., Kim, J.-H., Shin, H.-Y., Lee, H., Yang, J. M., Kim, J., Sohn, J.-H., Kim, H., & Yun, C.-O. (2003) · Human Gene Therapy · doi:10.1089/104303403769211637 · Cited by 109
Aging and cancer: are telomeres and telomerase the connection?
Shay, J. W. (1995) · Molecular Medicine Today · doi:10.1016/s1357-4310(95)93872-9 · Cited by 116
Brain Tumor Microvesicles: Insights into Intercellular Communication in the Nervous System
van der Vos, K. E., Balaj, L., Skog, J., & Breakefield, X. O. (2011) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-011-9697-y · Cited by 103
“Telomerase RNA Telomere synthesis ( Feng et al. 1995 )N o”
MethodTelomerase activity is required for bleomycin-induced pulmonary fibrosis in mice
Liu, T., Chung, M. J., Ullenbruch, M., Yu, H., Jin, H., Hu, B., Choi, Y. Y., Ishikawa, F., & Phan, S. H. (2007) · Journal of Clinical Investigation · doi:10.1172/jci32369 · Cited by 104
“The RNA component is constitutively expressed in both normal and cancerous tissues expressing telomerase activity, but can also be detected in cells and tissues lacking detectable telomerase activity (2, 3).”
BackgroundGeneral gambogic acids inhibited growth of human hepatoma SMMC-7721 cells in vitro and in nude mice.
Qing-longGUO, Qi-dongYOU, Zhao-qiuWU, Sheng-taoYUAN, & LiZhao (2004) · PubMed · Cited by 108
Takakura, M., Kyo, S., Inoue, M., Wright, W. E., & Shay, J. W. (2005) · Molecular and Cellular Biology · doi:10.1128/mcb.25.18.8037-8043.2005 · Cited by 107
“The other core component is the enzymatic reverse transcriptase catalytic protein subunit (hTERT) (11, 28, 29).”
BackgroundJagadeesh, S., Kyo, S., & Banerjee, P. P. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-2494 · Cited by 113
Origin, Diversity, and Evolution of Telomere Sequences in Plants
Peška, V., & Garcia, S. (2020) · Frontiers in Plant Science · doi:10.3389/fpls.2020.00117 · Cited by 114
Antisense therapeutics: from theory to clinical practice
Pirollo, K. F., Rait, A. S., Sleer, L. S., & Chang, E. H. (2003) · Pharmacology & Therapeutics · doi:10.1016/s0163-7258(03)00053-6 · Cited by 124
“In fact, Feng et al. (1995) employed AS ONs to identify the RNA component of human telomerase.”
BackgroundSelf-citationBryce, L. A., Morrisont, N., Hoare, S. F., Muir, S., & Keith, W. N. (2000) · Neoplasia · doi:10.1038/sj.neo.7900092 · Cited by 105
Telomerase activity and the expression of telomerase components in acute myelogenous leukaemia
XU, D., Gruber, A., Peterson, C., & Pisa, P. (1998) · British Journal of Haematology · doi:10.1046/j.1365-2141.1998.00969.x · Cited by 107
“…(hTR) and telomerase-associated protein (TP1) showed that hTR and TP1 were expressed in both normal and malignant human cells and that their expression did not relate to telomerase activity (Feng et al, 1995; Harrington et al, 1997; Kuniyasu et al, 1997; Nakamura et al, 1997; Soder et al, 1997).”
BackgroundDome, J. S., CHUNG, S. S., Bergemann, T. L., Umbricht, C. B., Saji, M., Carey, L., Grundy, P. E., Perlman, E. J., Breslow, N. E., & Sukumar, S. V. (1999) · PubMed · Cited by 120
Narala, S. R., Allsopp, R. C., Wells, T. B., Zhang, G., Prasad, P., Coussens, M. J., Rossi, D. J., Weissman, I. L., & Vaziri, H. (2008) · Molecular Biology of the Cell · doi:10.1091/mbc.e07-09-0965 · Cited by 106
Self-citationNon-canonical Roles of Telomerase: Unraveling the Imbroglio
Ségal-Bendirdjian, E., & Géli, V. (2019) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2019.00332 · Cited by 113
Telomerase Activity Does Not Always Imply Telomere Maintenance
Ouellette, M. M., Aisner, D. L., Savre‐Train, I., Wright, W. E., & Shay, J. W. (1999) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1998.0114 · Cited by 117
Small-Molecule PAPD5 Inhibitors Restore Telomerase Activity in Patient Stem Cells
Nagpal, N., Wang, J., Zeng, J., Lo, E., Moon, D. H., Luk, K., Braun, R. O., Burroughs, L. M., Keel, S. B., Reilly, C., et al. (2020) · Cell Stem Cell · doi:10.1016/j.stem.2020.03.016 · Cited by 105
“To maintain replicative capacity, human stem cells express the reverse transcriptase TERT, which together with the non-coding RNA template TERC comprise a functional telomerase ribonucleoprotein (RNP) to replenish telomere repeats (Feng et al., 1995; Meyerson et al., 1997; Nakamura et al., 1997).”
BackgroundHippocampal telomerase is involved in the modulation of depressive behaviors
Zhou, Q.-G., Hu, Y., Wu, D.-L., Zhu, L.-J., Chen, C., Jin, X., Luo, C.-X., Wu, H.-Y., Zhang, J., & Zhu, D.-Y. (2011) · The Journal of Neuroscience · doi:10.1523/jneurosci.0805-11.2011 · Cited by 105
“In proliferative cells, telomere length is maintained by telomerase, a DNA polymerase that consists of an RNA component (TERC) and a catalytic subunit, telomerase reverse transcriptase (TERT), and adds six-base DNA repeats (TTAGGG) onto the telomeric ends of chromosomes (Feng et al., 1995; Blackburn, 2001).”
BackgroundTelomere dysfunction in genome instability syndromes
Callén, E., & Surrallés, J. (2004) · Mutation Research/Reviews in Mutation Research · doi:10.1016/j.mrrev.2004.06.003 · Cited by 119
The effect of TERC haploinsufficiency on the inheritance of telomere length
Goldman, F., Bouarich, R., Kulkarni, S., Freeman, S., Du, H.-Y., Harrington, L., Mason, P. J., Londoño-Vallejo, A., & Bessler, M. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0505318102 · Cited by 106
Presence of telomeric G‐strand tails in the telomerase catalytic subunit TERT knockout mice
Yuan, X., Ishibashi, S., Hatakeyama, S., Saito, M., Nakayama, J., Nikaido, R., Haruyama, T., Watanabe, Y., Iwata, H., Iida, M., et al. (1999) · Genes to Cells · doi:10.1046/j.1365-2443.1999.00284.x · Cited by 105
“RT-PCR was performed with 1 mg of total RNAs extracted from adult testes of mTERT / and mTERT ÿ/ÿ mice using the primers 50-2 and 30-1 (primer 50-2 located in exon a, 50-CTTGAGAGAGTGCGGCTACGGGAGCT-30; primer 30-1 located in exon k, 50-AAGACCGACAGGAGCTTGT TCCGCAT-30).”
InfluentialXu, D., Erickson, S., Szeps, M., Gruber, A., Sangfelt, O., Einhorn, S., Pisa, P., & Grandér, D. (2000) · Blood · doi:10.1182/blood.v96.13.4313 · Cited by 104
Curcumin as Prospective Anti-Aging Natural Compound: Focus on Brain
Benameur, T., Soleti, R., Panaro, M. A., La Torre, M. E., Monda, V., Messina, G., & Porro, C. (2021) · Molecules · doi:10.3390/molecules26164794 · Cited by 100
Genetic and epigenetic changes in stomach cancer
Yokozaki, H., Yasui, W., & Tahara, E. (2001) · International review of cytology · doi:10.1016/s0074-7696(01)04003-7 · Cited by 112
Heppner Goss, K. J., Brown, P. D., & Matrisian, L. M. (1998) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(19981123)78:5<629::aid-ijc17>3.0.co;2-8 · Cited by 95
Vaziri, H., Squire, J. A., Pandita, T. K., Bradley, G., Kuba, R. M., Zhang, H., Gulyas, S., Hill, R. P., Nolan, G. P., & Benchimol, S. (1999) · Molecular and Cellular Biology · doi:10.1128/mcb.19.3.2373 · Cited by 105
Albanell, J., Han, W., Mellado, B., Gunawardane, R. N., Scher, H. I., Dmitrovsky, E., & Moore, M. A. S. (1996) · PubMed · Cited by 105
Yudoh, K., Matsuno, H., Nakazawa, F., Katayama, R., & Kimura, T. (2001) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.2001.16.8.1453 · Cited by 103
“Recently, three components, human telomerase reverse transcriptase (hTERT), (23–27) the human telomerase RNA (hTR) component, (28) and the human telomerase-associated protein (hTP1), (29) have been identified that are associated with telomerase activity.”
BackgroundKnight, J. S., Cotter, M. A., & Robertson, E. S. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m101890200 · Cited by 108
Cellular lifespan and senescence signaling in embryonic stem cells
Miura, T., Mattson, M. P., & Rao, M. S. (2004) · Aging Cell · doi:10.1111/j.1474-9728.2004.00134.x · Cited by 102
Sæbøe‐Larssen, S., Fossberg, E., & Gaudernack, G. (2006) · BMC Molecular Biology · doi:10.1186/1471-2199-7-26 · Cited by 115
Nucleostemin Delays Cellular Senescence and Negatively Regulates TRF1 Protein Stability
Zhu, Q., Yasumoto, H., & Tsai, R. Y. L. (2006) · Molecular and Cellular Biology · doi:10.1128/mcb.00724-06 · Cited by 109
“The telomere length is maintained by the telomerase (TERT) (2, 8, 18) and several telomere-binding proteins, including TRF1 (26), TRF2 (6), and TRF1-interacting nuclear protein 2 (TIN2) (12).”
BackgroundOne-step affinity purification protocol for human telomerase
Schnapp, G. (1998) · Nucleic Acids Research · doi:10.1093/nar/26.13.3311 · Cited by 101
Specific DNA Replication Mutations Affect Telomere Length in Saccharomyces cerevisiae
Adams, A. K., & Holm, C. (1996) · Molecular and Cellular Biology · doi:10.1128/mcb.16.9.4614 · Cited by 101
Novel mechanisms for antisense-mediated regulation of gene expression
Baker, B. F., & Monia, B. P. (1999) · Biochimica et Biophysica Acta (BBA) - Gene Structure and Expression · doi:10.1016/s0167-4781(99)00146-3 · Cited by 118
Hou, P., Shi, P.-C., Jiang, T., Yin, H., Chu, S., Shi, M., Bai, J., & Song, J. H. (2019) · British Journal of Cancer · doi:10.1038/s41416-019-0695-z · Cited by 110
Biochemical aspects of telomerase function
Harrington, L. A. (2003) · Cancer Letters · doi:10.1016/s0304-3835(02)00701-2 · Cited by 118
The C terminus of the human telomerase reverse transcriptase is a determinant of enzyme processivity
Huard, S., Moriarty, T. J., & Autexier, C. (2003) · Nucleic Acids Research · doi:10.1093/nar/gkg437 · Cited by 120
“A short sequence within hTR serves as a template for de novo addition of telomere sequences (4).”
BackgroundEvaluation of Drug–Nucleic Acid Interactions by Thermal Melting Curves
Wilson, W. D., Tanious, F. A., Fernandez‐Saiz, M., & Rigl, C. T. (2003) · Humana Press eBooks · doi:10.1385/0-89603-447-x:219 · Cited by 105
Pendino, F., Flexor, M., Delhommeau, F., Selimoglu‐Buet, D., Lanotte, M., & Ségal-Bendirdjian, E. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.111464998 · Cited by 103
Telomeres and Age-Related Diseases
Gruber, H.-J., Semeraro, M. D., Renner, W., & Herrmann, M. (2021) · Biomedicines · doi:10.3390/biomedicines9101335 · Cited by 94
Overexpression ofLAMP3/TSC403/DC-LAMPPromotes Metastasis in Uterine Cervical Cancer
Kanao, H., Enomoto, T., Kimura, T., Fujita, M., Nakashima, R., Ueda, Y., Ueno, Y., Miyatake, T., Yoshizaki, T., Buzard, G. S., et al. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-4112 · Cited by 100
“Another possible 3q gene is hTR , which encodes the RNA component of human telomerase (20).”
BackgroundCerezo, A., Kalthoff, H., Schuermann, M., Schäfer, B., & Boukamp, P. (2002) · Journal of Cell Science · doi:10.1242/jcs.115.6.1305 · Cited by 101
Spontaneous and radiation-induced chromosomal breakage at interstitial telomeric sites
Slijepčević, P., Xiao, Y., Domínguez, I., & Natarajan, A. T. (1996) · Chromosoma · doi:10.1007/bf00352299 · Cited by 107
“Telomerase activity in vivo is not restricted to chromosomal ends as shown by the formation of new telomeres at previously interstitial chromosomal sites ( Farr et al. 1991; Yu and Blackburn 1991; Barnett etal.”
BackgroundSaretzki, G. C., Ludwig, A., von Zglinicki, T., & Runnebaum, I. B. (2001) · Cancer Gene Therapy · doi:10.1038/sj.cgt.7700383 · Cited by 109
“It has been suggested repeatedly that the antiproliferative effect of telomerase inhibition would be mediated by shortening of telomeres.(12,16,17) We found strong induction of cell death already within 2–4 days after AdR4 transduction in four ovarian cancer cell lines (Fig 4).”
BackgroundNakano, K., Watney, E., & McDougall, J. K. (1998) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)65627-1 · Cited by 103
Blasco, M. A., Gasser, S. M., & Lingner, J. (1999) · Genes & Development · doi:10.1101/gad.13.18.2353 · Cited by 120
“In mammals and yeast, the telomerase RNAs are much longer—450 and 1300 nucleotides, respectively (Singer and Gottschling 1994; Blasco et al. 1995; Feng et al. 1995)—and it is unclear which structural elements may be universally conserved.”
BackgroundOhyashiki, K., Ohyashiki, J. H., Nishimaki, J., Toyama, K., Ebihara, Y., Kato, H., Wright, W. E., & Shay, J. W. (1997) · PubMed · Cited by 98
Human telomerase reverse transcriptase (hTERT) gene expression in thyroid neoplasms.
Saji, M., Xydas, S., Westra, W. H., Liang, C. K., Clark, D. P., Udelsman, R., Umbricht, C. B., Sukumar, S. V., & Zeiger, M. A. (1999) · PubMed · Cited by 103
The snoRNA domain of vertebrate telomerase RNA functions to localize the RNA within the nucleus.
Lukowiak, A. A., Narayanan, A., Li, Z., Terns, R. M., & Terns, M. P. (2001) · Europe PMC (PubMed Central) · Cited by 119
Treatment of prostate cancer in vitro and in vivo with 2-5A-anti-telomerase RNA component
Kondo, Y., Koga, S., Komata, T., & Kondo, S. (2000) · Oncogene · doi:10.1038/sj.onc.1203538 · Cited by 98
“Without telomerase, normal cells lose some of telomeric DNA with each cell division, and enter senescence or stop proliferation when telomeres reach a critical length (Harley et al., 1990; Hastie et al., 1990; Allsopp et al., 1995).”
BackgroundInfluentialTelomerase inhibition, oligonucleotides, and clinical trials
Corey, D. R. (2002) · Oncogene · doi:10.1038/sj.onc.1205063 · Cited by 106
“Telomerase consists of an RNA component (hTR) that acts to bind the telomere (Feng et al., 1995) and a protein component (hTERT) that acts as a reverse transcriptase (Meyerson et al., 1997, Harrington et al., 1997; Nakamura et al., 1997).”
BackgroundZhuang, Y., Huang, F., Xu, Q., Zhang, M., Lou, X., & Xia, F. (2016) · Analytical Chemistry · doi:10.1021/acs.analchem.5b04756 · Cited by 98
Metadata
- Authors
- Feng, J., Funk, W. D., Wang, S.-S., Weinrich, S. L., Avilion, A. A., Chiu, C.-P., Adams, R. R., Chang, E., Allsopp, R. C., Yu, J., Le, S., West, M. D., Harley, C. B., Andrews, Greider, C. W., & Villeponteau, B.
- Affiliations
- Geron (United States) (US)
- Cold Spring Harbor Laboratory (US)
- ORCID
- Venue
- Science
- Published
- 1995-09
- Volume
- 269
- Issue
- 5228
- Pages
- 1236-1241
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- OpenAlex
- W2026856852
- Cited by
- 2,227
- References
- 44
- Citations by year
- 2026: 10 · 2025: 23 · 2024: 20 · 2023: 36 · 2022: 35 · 2021: 33 · 2020: 44 · 2019: 52 · 2018: 55 · 2017: 44 · 2016: 74 · 2015: 54 · 2014: 47 · 2013: 62 · 2012: 61
- FWCI
- 54.67
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Science (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institute on Aging (AG09383)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Telomeres, Telomerase, and Senescence
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Aging › Genetics, Aging, and Longevity in Model Organisms
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › DNA and Nucleic Acid Chemistry
- Keywords
- telomerase, hTR, telomeric repeats, antisense RNA, telomere shortening, HeLa cells
- MeSH terms
- Animals, Base Sequence, Cell Division, Cell Line, Cloning, Molecular, DNA Nucleotidylexotransferase, HeLa Cells, Humans, Molecular Sequence Data, RNA, Templates, Genetic, Transfection, Tumor Cells, Cultured, Polymerase Chain Reaction, Oligonucleotides, Antisense, Cell Death
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.